"Breast Neoplasms, Male" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any neoplasms of the male breast. These occur infrequently in males in developed countries, the incidence being about 1% of that in females.
|Breast Neoplasms, Male
- Breast Neoplasms, Male
- Breast Neoplasm, Male
- Male Breast Neoplasm
- Neoplasm, Male Breast
- Tumors, Breast, Male
- Neoplasms, Breast, Male
- Neoplasms, Male Breast
- Breast Tumors, Male
- Breast Tumor, Male
- Male Breast Tumor
- Male Breast Tumors
- Tumor, Male Breast
- Tumors, Male Breast
- Male Breast Neoplasms
Male Breast Cancer
- Male Breast Cancer
- Cancer, Male Breast
- Breast Carcinoma, Male
- Carcinoma, Male Breast
- Male Breast Carcinoma
- Breast Cancer, Male
Below are MeSH descriptors whose meaning is more general than "Breast Neoplasms, Male".
Below are MeSH descriptors whose meaning is more specific than "Breast Neoplasms, Male".
This graph shows the total number of publications written about "Breast Neoplasms, Male" by people in this website by year, and whether "Breast Neoplasms, Male" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Breast Neoplasms, Male" by people in Profiles.
Schwartz CJ, Schandl CA, Morse J, Ralston J, Rapkiewicz A, Darvishian F. Benign Fibromyxoid Lesion of the Breast: A Distinct Entity From Benign Spindle Cell Tumors of the Mammary Stroma? Int J Surg Pathol. 2018 Sep; 26(6):488-493.
Jezierska-Drutel A, Rosenzweig SA, Neumann CA. Role of oxidative stress and the microenvironment in breast cancer development and progression. Adv Cancer Res. 2013; 119:107-25.
Leddy R, Cluver A. Mammographic and sonographic characteristics of a cavernous hemangioma in a male patient. J Ultrasound Med. 2010 Apr; 29(4):645-9.
Walsh MD, Buchanan DD, Cummings MC, Pearson SA, Arnold ST, Clendenning M, Walters R, McKeone DM, Spurdle AB, Hopper JL, Jenkins MA, Phillips KD, Suthers GK, George J, Goldblatt J, Muir A, Tucker K, Pelzer E, Gattas MR, Woodall S, Parry S, Macrae FA, Haile RW, Baron JA, Potter JD, Le Marchand L, Bapat B, Thibodeau SN, Lindor NM, McGuckin MA, Young JP. Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry. Clin Cancer Res. 2010 Apr 01; 16(7):2214-24.
Forman SB, Tyler WB, Dorion RP, Elston DM. Breast carcinoma in a male: importance of hormonal receptor expression and possibility of a familial cancer syndrome. J Am Acad Dermatol. 2007 Oct; 57(4):731-2.
Stitzenberg KB, Calvo BF, Iacocca MV, Neelon BH, Sansbury LB, Dressler LG, Ollila DW. Cytokeratin immunohistochemical validation of the sentinel node hypothesis in patients with breast cancer. Am J Clin Pathol. 2002 May; 117(5):729-37.
Alberg AJ, Lam AP, Helzlsouer KJ. Epidemiology, prevention, and early detection of breast cancer. Curr Opin Oncol. 1999 Nov; 11(6):435-41.
Lockett MA, Metcalf JS, Baron PL, O'Brien PH, Elliott BM, Robison JG, Cole DJ. Efficacy of reverse transcriptase-polymerase chain reaction screening for micrometastic disease in axillary lymph nodes of breast cancer patients. Am Surg. 1998 Jun; 64(6):539-43; discussion 543-4.